Literature DB >> 29287259

Correlation of dissolution and disintegration results for an immediate-release tablet.

Beverly Nickerson1, Angela Kong2, Paul Gerst3, Shangming Kao4.   

Abstract

The drug release rate of a rapidly dissolving immediate-release tablet formulation with a highly soluble drug is proposed to be controlled by the disintegration rate of the tablet. Disintegration and dissolution test methods used to evaluate the tablets were shown to discriminate manufacturing process differences and compositionally variant tablets. In addition, a correlation was established between disintegration and dissolution. In accordance with ICH Q6A, this work demonstrates that disintegration in lieu of dissolution is suitable as the drug product quality control method for evaluating this drug product.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Correlation; Disintegration; Dissolution; Immediate-release tablets

Mesh:

Substances:

Year:  2017        PMID: 29287259     DOI: 10.1016/j.jpba.2017.12.017

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Development and Validation of a Discriminatory Dissolution Model for an Immediately Release Dosage Form by DOE and Statistical Approaches.

Authors:  Mingkun Fu; Ellen Conroy; Michael Byers; Lakshminarasimhan Pranatharthiharan; Thierry Bilbault
Journal:  AAPS PharmSciTech       Date:  2021-04-21       Impact factor: 3.246

2.  Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times.

Authors:  Maoqi Fu; Jozef Al-Gousous; Johannes Andreas Blechar; Peter Langguth
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

3.  Fused Deposition Modeling as a Possible Approach for the Preparation of Orodispersible Tablets.

Authors:  Thao Tranová; Jolanta Pyteraf; Mateusz Kurek; Witold Jamróz; Witold Brniak; Dita Spálovská; Jan Loskot; Karolina Jurkiewicz; Joanna Grelska; Daniel Kramarczyk; Jitka Mužíková; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.